Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy and Safety of SPD465 in Adults With Moderately Symptomatic ADHD.

This study has been completed.
Information provided by:
Shire Identifier:
First received: September 7, 2005
Last updated: November 2, 2007
Last verified: November 2007